San Francisco, CA, Jan. 9, 2020 – Quara Devices Inc, is a privately held company with an entirely new technology platform that measures the signature of infectious bacteria, enabling real-time and rapid response in medical, veterinary, pharmaceutical and aquatic applications. ...

SAN FRANCISCO, Jan. 9, 2020 – LACHESIS BIOSCIENCES LTD, a clinical-stage biotechnology company targeting dementia caused by Alzheimer’s and Parkinson’s disease, announced today that its chief executive officer, Dr. Tim Morgan, will present at the Biotech Showcase 2020 confer...

Edmonton, Alberta, Canada, Jan. 9, 2020 – PACYLEX PHARMACEUTICALS, INC. a pre-IND-stage pharmaceutical company targeting hematologic cancers with a new first-in-class therapeutic, announced today that its chief executive officer, Michael Weickert, will present at the Biotech S...

Cancer-focused biotechnology company Kazia Therapeutics will present recent positive interim efficacy data on its lead program, paxalisib, at Biotech Showcase in San Francisco. Paxalisib (formerly known as GDC-0084) is a small molecule inhibitor of the PI3K pathway, which is b...

Montreal, Canada and Wuhan, China, January 9, 2020 -- Phagelux, Inc. today announced that it has scheduled a company presentation at Biotech Showcase™ 2020. Mark Engel, CEO, will be presenting Phagelux at Biotech Showcase as follows: Date: Tuesday, January 14, 2020 Time: 3:45 ...

NEW YORK, Jan. 9, 2020 – Virtual Health Partners (VHP), a leading virtual health and wellness company, announced that CEO & Co-Founder Jillian Bridgette Cohen and CFO Bill Giles will present a corporate overview at the Biotech Showcase and Digital Medicine & Medtech Showcase, ...

VIENNA, Jan. 9, 2020 – PhagoMed Biopharma GmbH, (PhagoMed) a pre-clinical biotechnology company targeting bacterial pathogens in antibiotic resistance and microbiome settings, announced today that its chief executive officer, Alexander Belcredi, will present at the Biotech Sho...

[NEW YORK] 8th Jan 2020 – DeckTherapeutics Inc today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15th, during the most important week in healthcare at the Hilton San Francisco Union Square. Suman Lal, MD PhD (CEO) wi...

BOSTON,MA (January 8, 2020)—Cure Rare Disease (CRD), the emerging, Boston-based nonprofit on a mission to develop precision medicine for rare diseases, is pleased to provide an annual review of its activities and accomplishments in 2019. Successful fundraising efforts have all...

San Francisco (California) January 6, 2020: NanoValent Pharmaceuticals, Inc., a development stage, cancer focused pharmaceutical company progressing a new class of targeted nanosphere therapeutics, today announced the publication of United States Patent No. 10,369,104 from the...